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5(IQR4-6) and 4(IQR4-5). In most patients (46/49), serious or repeated
bleeding was the procedural indication. Conscious sedation was ach-
ieved in all patients using midazolam 1.5mg (IQR1-2) and fentanyl
100mcg (IQR 75-150). Devices implanted included the Amplatzer
Cardiac PlugTM in 22, AmuletTM (St.Jude Medical Inc.) in 20 and
UltraSeptTM LAA Occluder (Cardia Inc, Eagen, MN) in 7. In all cases
ICE provided adequate LAA visualization, procedural guidance, oc-
clusion assessment, and device visualization and its relation with
adjacent structures. Procedural success was achieved in all but 1 pa-
tient (challenging anatomy and consequent failure to implant the
device). Median procedural time was 91min (IQR 81-119). Median
hospital stay was 1 day. There was no procedural stroke or device
embolization. Two patients developed tamponade, one treated with
pericardiocentesis and 1 required surgical repair. Two patients had
access site hematomas. No ICE related complication was noted. At 3
months 87% of patients had clinical and TEE follow-up. Non-clinically
signiﬁcant residual interatrial shunts were found in 7/42. Successful
LAA occlusion was observed in 41 of the 42 patients with follow-up
TEE; one patient had a 4 mm residual leak. Three patients died during
this period, all were non-procedure related deaths. Two patients had a
recurrent GI bleeding and were hospitalized for transfusions.
CONCLUSIONS This pilot experience suggests that LAA occlusion in
conscious patients under ICE guidance from the left atrium offers
comprehensive LAA visualization, complete and reliable procedural
guidance and outcomes are in line with those of the TEE-guided se-
ries. This technique stands as a valid alternative for general anes-
thesia and TEE guidance for percutaneous LAA occlusion.
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BACKGROUND Interventional left atrial appendage (LAA) occlusion
has been shown to be non-inferior to warfarin therapy. Thus, the
Watchman device (Boston Scientiﬁc, Marlborough, MA, USA) has
recently been approved by the FDA for clinical use as alternative to
warfarin in the United States. Therefore, a massive increase in per-
formed LAA occlusions can be expected worldwide. However, peri-
procedural stroke has been a major contributor to adverse events in
clinical trials. A similar problem was encountered in the ﬁeld of
transcatheter aortic valve replacement (TAVR). In TAVR, the use of a
cerebral protection device (Sentinel CPS, Claret Medical Inc., Santa
Rosa, CA, USA) has been proven to reduce cerebral lesions as assessed
with magnetic resonance imaging (MRI). We hypothesized, that the
less invasive procedure of LAA occlusion leads to embolization of
solid material, too and that the use of a cerebral protection system
might reduce adverse events in LAA occlusion and even reduce long-
term adverse effects of microemboli like cognitive deterioration.
METHODS In ﬁve consecutive patients treated with LAA occlusion in
our center the Sentinel CPS cerebral protection device was used. For
LAA occlusion, the Watchman device was used in two patients and
the Amulet (St. Jude Medical Inc., St. Paul, MN, USA) in three pa-
tients. The procedures were performed according to the instructions
for use. Presence of LAA thrombus was ruled out before the procedure
by transesophageal echocardiography in all patients, the ﬁlters placed
after the transeptal puncture. Throughout the procedure, unfractio-
nated heparin was administered to maintain an activated clotting
time > 250 seconds. After LAA occlusion the ﬁlters were removed and
their content underwent histologic examination.
RESULTS A total of 10 ﬁlters (one proximal and one distal ﬁlter for each
patient)were collected andunderwentHistopathologic analysis (CVPath
Institute Inc.). Debris was found in all patients (9/10 ﬁlters). Acute
thrombus was found in 3 patients (2 Watchman; 1 Amulet), organizing
thrombus in 4 patients (1 Watchman; 3 Amulet). One Amulet patient
showed endocardial tissue and one other platelets in theirﬁlters. None of
the ﬁlters included calciﬁcations or other foreign material. The maximal
diameter of the collected material was 0.68 (0.9) mm. No patient
showed neurological abnormalities after the procedure.
CONCLUSIONS As expected the procedure of LAA occlusion leads to
embolization of thrombus material, either preexisting or induced bythe procedure, in all patients. This ﬁnding strongly encourages further
investigations of the underlying mechanisms for embolization of
different types of material, as well as the clinical impact of micro-
emboli. A potential difference between different devices in throm-
bogenic potential as seen in our small series should also be addressed
in future investigations and might help to improve device design and
implantation techniques.
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BACKGROUND We have previously reported a less invasive off-pump
epicardial ventricular enhancement (LIVE) procedure, which involves
an open chest exposure with placement of an anchoring system in an
experimental heart failure animal model. This study aimed to evaluate
whether a novel hybrid transcatheter ventricular restoration (TCVR)
approach, with thoracoscopic assistance, can achieve similar results in
an ovinemodel of ischemic heart failure and LV anteroseptal aneurysm
METHODS Left ventricular (LV) anteroseptal scar was created by
percutaneous coil-occlusion of the mid-left anterior descending cor-
onary artery. Two months later, the scar was completely excluded via
placement of serial pairs of anchors in the right ventricular septum
and LV anterior epicardium through either open chest surgical
approach (n¼8) or minimal invasive hybrid TCVR approach (n¼5). LV
performance was evaluated before (baseline) and six weeks after de-
vice implantation by echocardiography.
RESULTS All animals survived with no device or procedure-related
complications. TCVR signiﬁcantly reduced LV end-systolic and end-
diastolic volumes and increased the ejection fraction while stroke
volume was preserved at 6 weeks follow-up; the apical rotation was
signiﬁcantly improved (4.3 1.3 vs. baseline 0.52.7; p¼0.03) and LV
twist was restored (8.563.45 vs. baseline 3.715.39⁰, p¼0.04). No
difference was shown between the two groups in volume reduction,
ejection fraction or LV twist improvement (Table).Change at 6 weeks FU
from pre-device TCVR (n[5) Surgical (n[8) p ValveLV end-diastolic
volume (ml)-2911 (32%) -1211 (18%) 0.09LV end-systolic
volume (ml)-288 (46%) -176 (36%) 0.62Stroke volume (ml) -18 410 0.33
Ejection fraction (%) 145 148 0.76
LV apical rotation () 3.812.67 1.832.18 0.21
LV twist () 4.863.74 3.092.01 0.37CONCLUSIONS Compared with a more invasive open-chest surgical
procedure, hybrid, thoracoscopically assisted TCVR can achieve
similar volume reduction and improvement in contractility of the LV
in an ovine model of ischemic cardiomyopathy with LV anteroseptal
infarction. It might be a safe, effective and less invasive alternative to
current open surgical therapies.
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